Genomic and ploidy manipulation for enhanced production of phyto-pharmaceuticals

2005 ◽  
Vol 3 (2) ◽  
pp. 170-177 ◽  
Author(s):  
U.C. Lavania

Polyploidization is often accompanied by increased cell size and conspicuous changes in secondary metabolism. Where vegetative plant organs are the source of secondary metabolites, as is the case with most medicinal plants, ploidy manipulations such as direct chromosome doubling or allopolyploidization provide a rapid means to realize enhanced production of phyto-pharmaceuticals. Supported with prospective examples, this article illustrates the potential of genomic and ploidy manipulation to enhance the resourcing of pharmaceuticals of plant origin and suggests some appropriate strategies for optimum utilization.

2021 ◽  
Author(s):  
Yulong Li ◽  
Wei Zhao ◽  
Xianghua Zuo ◽  
Biao Ni ◽  
Jian You ◽  
...  

Abstract Background: With the increasing use of traditional herbal medicine, the issue of the genetic diversity of medicinal plants has received considerable critical attention. A high degree of genetic diversity is the basis for maintaining the stability and long-term survival of the population, so the changes in genetic diversity and genetic structure of cultivated medicinal plants caused by habitat changes can not be ignored; Meanwhile, the difference of secondary metabolism of medicinal plants caused by habitat change is also deserving of attention simultaneously. And It is also worth pondering whether the changes between them are consistent. Results: In this study, the wild and cultivated populations of Polygonatum odoratum, Dioscorea nipponica and Acanthopanax sessiliflorus were selected as the research objects. and the genetic structure and HPLC fingerprint between wild and cultivated populations were compared and analyzed by using Simple Sequence Repeats (SSR) marker and HPLC . The results demonstrated that the wild and cultivated populations of the three medicinal plants maintained higher genetic diversity, however, the genetic structure of wild populations of P.odoratum and D.nipponica is more similar. In addition, there was a great genetic differentiation between P.odoratum and D.nipponica populations. There were significant differences in HPLC fingerprints among different populations, in which the secondary metabolites of wild populations were more complex, nevertheless, there was less difference in HPLC fingerprints between wild and cultivated populations of P.odoratum and D.nipponica. Spearman correlation analysis implied that environmental factors (including soil environmental factors, rainfall, temperature) had significant effects on the secondary metabolites of the three medicinal plants, whereas, soil environmental factors had less effect on the genetic structure of the three medicinal plants. Conclusion: In conclusion, during the cultivation years, environmental factors only have a significant effect on the secondary metabolism of the three medicinal plants, their populations still maintain higher genetic diversity and stable genetic structure, what’s more, the secondary metabolites of the same medicinal plants with stable and similar genetic structure may still be different from each other when the habitat is changed. It indicated that there is no obvious consistency between them during the cultivation years.


2018 ◽  
pp. 30-36
Author(s):  
V. M. Minarchenko ◽  
A. Yu. Butko

The popularity of herbal remedies and medicines, with the participation of biologically active substances from plants is traditionally high. The annual increase of the domestic market for herbal remedies is due to the preservation and modernization of production capacities for processing of medicinal vegetative raw materials in Ukraine, introduction of modern scientific developments, a large natural resource base of medicinal plants and attracting investments in the development of this industry. The aim of our work was the study of the domestic market of medicines of plant origin, which includes herbal remedies, substances and preparations with the participation of biologically active substances from plants. The object of the study was domestic medicines of plant origin that are registered in Ukraine for 2012–2017. The study used the analytical, statistical methods, and the results of its own resource studies of medicinal plants. Phytopharmaceutical market of Ukraine is actively developing due to the attraction of new types of medicinal plants and expanding the range of medicines. The number of domestic drugs with the participation of biologically active substances from plants has increased by 17.4% compared with 2014. It is established that as of 1 January 2017 in Ukraine was 1 141 the form of medicinal drugs of plant origin. Of them: 645 – domestic products, 496 – foreign. Most of the herbal drugs in the pharmaceutical market of Ukraine are made from wild and cultivated domestic raw materials.


2021 ◽  
Vol 14 (11) ◽  
pp. 1145
Author(s):  
Chabaco Armijos ◽  
Jorge Ramírez ◽  
Melissa Salinas ◽  
Giovanni Vidari ◽  
Alírica I. Suárez

The use of plants as therapeutic agents is part of the traditional medicine that is practiced by many indigenous communities in Ecuador. The aim of this study was to update a review published in 2016 by including the studies that were carried out in the period 2016–July 2021 on about 120 Ecuadorian medicinal plants. Relevant data on raw extracts and isolated secondary metabolites were retrieved from different databases, resulting in 104 references. They included phytochemical and pharmacological studies on several non-volatile compounds, as well as the chemical composition of essential oils (EOs). The tested biological activities are also reported. The potential of Ecuadorian plants as sources of products for practical applications in different fields, as well the perspectives of future investigations, are discussed in the last part of the review.


mBio ◽  
2015 ◽  
Vol 6 (4) ◽  
Author(s):  
Michalis Hadjithomas ◽  
I-Min Amy Chen ◽  
Ken Chu ◽  
Anna Ratner ◽  
Krishna Palaniappan ◽  
...  

ABSTRACTIn the discovery of secondary metabolites, analysis of sequence data is a promising exploration path that remains largely underutilized due to the lack of computational platforms that enable such a systematic approach on a large scale. In this work, we present IMG-ABC (https://img.jgi.doe.gov/abc), an atlas of biosynthetic gene clusters within the Integrated Microbial Genomes (IMG) system, which is aimed at harnessing the power of “big” genomic data for discovering small molecules. IMG-ABC relies on IMG's comprehensive integrated structural and functional genomic data for the analysis of biosynthetic gene clusters (BCs) and associated secondary metabolites (SMs). SMs and BCs serve as the two main classes of objects in IMG-ABC, each with a rich collection of attributes. A unique feature of IMG-ABC is the incorporation of both experimentally validated and computationally predicted BCs in genomes as well as metagenomes, thus identifying BCs in uncultured populations and rare taxa. We demonstrate the strength of IMG-ABC's focused integrated analysis tools in enabling the exploration of microbial secondary metabolism on a global scale, through the discovery of phenazine-producing clusters for the first time inAlphaproteobacteria. IMG-ABC strives to fill the long-existent void of resources for computational exploration of the secondary metabolism universe; its underlying scalable framework enables traversal of uncovered phylogenetic and chemical structure space, serving as a doorway to a new era in the discovery of novel molecules.IMPORTANCEIMG-ABC is the largest publicly available database of predicted and experimental biosynthetic gene clusters and the secondary metabolites they produce. The system also includes powerful search and analysis tools that are integrated with IMG's extensive genomic/metagenomic data and analysis tool kits. As new research on biosynthetic gene clusters and secondary metabolites is published and more genomes are sequenced, IMG-ABC will continue to expand, with the goal of becoming an essential component of any bioinformatic exploration of the secondary metabolism world.


Sign in / Sign up

Export Citation Format

Share Document